Coronaviruses are composed of several proteins, including the spike, envelope, membrane, and nucleocapsid proteins. A set of assay platforms are used to detect antibodies to COVID-19. These are designed to detect antibodies binding to the recombinant S1 domain of SARS-CoV-2 spike protein and the nucleocapsid protein.